Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 3Completed 2Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 256INDUSTRY 159NIH 45NETWORK 6OTHER_GOV 2FED 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 1

Conditions

Breast Neoplasms 107Neoplasms 80Colorectal Neoplasms 54Uterine Cervical Neoplasms 29Stomach Neoplasms 29Lung Neoplasms 27Rectal Neoplasms 25Prostatic Neoplasms 25Colonic Neoplasms 24Polycystic Ovary Syndrome 22Pancreatic Neoplasms 22Head and Neck Neoplasms 17Endometrial Neoplasms 17Carcinoma, Non-Small-Cell Lung 16Carcinoma, Hepatocellular 16Pain 15Neoplasm Metastasis 15Motor Activity 15Esophageal Neoplasms 15Ovarian Neoplasms 13Urinary Bladder Neoplasms 11Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Pain, Postoperative 10Melanoma 10Thyroid Neoplasms 9Pilonidal Sinus 9Multiple Myeloma 9Gastrointestinal Neoplasms 9Sarcopenia 8

Interventions

nilotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER_GOV × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Clear all
NCT02161978 2019-11-06

DYVA-AAGG

University Hospital, Angers

Completed
93 enrolled
MyeloidOther hematologic neoplasm

Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00750659 2016-04-20

Nilotinib Pre and Post Allogeneic Stem Cell Transplantation

Sheba Medical Center

Phase 2 Completed
24 enrolled
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡